ConductScience.org, home

Paper36969583

Simultaneous quantitative analysis and in vitro anti-arthritic effects of five polyphenols from Terminalia chebula.

Liu F and 12 others. Front Physiol, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Simultaneous quantitative analysis and in vitro anti-arthritic effects of five polyphenols from Terminalia chebula. Papers, record 36969583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969583

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Simultaneous quantitative analysis and in vitro anti-arthritic effects of five polyphenols from Terminalia chebula.
PubMed
Journal
Front Physiol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.88
iCite
Revised in PubMed
2023-03-28
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu FFang
2Zhan SShipeng
3Zhang PPu
4Jia CChangsheng
5Zhu QQingzong
6Dai QQing
7Yu MMingjie
8Cheng LLin
9Xiong LLirong
10Sun FFengjun
11Xia PPeiyuan
12Zhang XXiao
13Hu JJing

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128822199[Progress on treatment of rheumatoid arthritis with ethnodrugs].Zhongguo Zhong Yao Za Zhi2017https://conductscience.org/library/papers/28822199PubMed
236730630Comprehensive Overview: The Effect of Using Different Solvents for Barley Extraction with Its Anti-Inflammatory and Antioxidant Activity.Chem Biodivers2023https://conductscience.org/library/papers/36730630PubMed
333257900The immunology of rheumatoid arthritis.Nat Immunol2021https://conductscience.org/library/papers/33257900PubMed
411120852Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun.J Immunol2000https://conductscience.org/library/papers/11120852PubMed
532307775Fruits of Terminalia chebula Retz.: A review on traditional uses, bioactive chemical constituents and pharmacological activities.Phytother Res2020https://conductscience.org/library/papers/32307775PubMed
617446889Estimation of total phenolic content and other oxidation substrates in plant tissues using Folin-Ciocalteu reagent.Nat Protoc2007https://conductscience.org/library/papers/17446889PubMed
729708818A Placebo-Controlled Double-Blind Study Demonstrates the Clinical Efficacy of a Novel Herbal Formulation for Relieving Joint Discomfort in Human Subjects with Osteoarthritis of Knee.J Med Food2018https://conductscience.org/library/papers/29708818PubMed
824669186
Genistein suppresses tumor necrosis factor α-induced inflammation via modulating reactive oxygen species/Akt/nuclear factor κB and adenosine monophosphate-activated protein kinase signal pathways in human synoviocyte MH7A cells.
Drug Des Devel Ther2014https://conductscience.org/library/papers/24669186PubMed
920451939
Polyphenolic compounds in the fruits of Egyptian medicinal plants (Terminalia bellerica, Terminalia chebula and Terminalia horrida): characterization, quantitation and determination of antioxidant capacities.
Phytochemistry2010https://conductscience.org/library/papers/20451939PubMed
1023939793Biological activities of phenolic compounds and triterpenoids from the galls of Terminalia chebula.Chem Biodivers2013https://conductscience.org/library/papers/23939793PubMed
1130341437Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis.Nat Rev Rheumatol2019https://conductscience.org/library/papers/30341437PubMed
1226656659Cytokines in rheumatoid arthritis - shaping the immunological landscape.Nat Rev Rheumatol2016https://conductscience.org/library/papers/26656659PubMed
1321054408Anti-arthritic and disease modifying activity of Terminalia chebula Retz. in experimental models.J Pharm Pharmacol2010https://conductscience.org/library/papers/21054408PubMed
149832620Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen.J Biochem1998https://conductscience.org/library/papers/9832620PubMed
1535055087Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells.Int J Mol Sci2022https://conductscience.org/library/papers/35055087PubMed
1632608988Validated Reverse Phase-High-Performance Liquid Chromatography Method for Estimation of Fisetin in Self-Nanoemulsifying Drug Delivery System.Assay Drug Dev Technol2020https://conductscience.org/library/papers/32608988PubMed
1732795901Chebulanin exerts its anti-inflammatory and anti-arthritic effects via inhibiting NF-κB and MAPK activation in collagen-induced arthritis mice.Int Immunopharmacol2020https://conductscience.org/library/papers/32795901PubMed
1831545276
Guizhi-Shaoyao-Zhimu decoction possesses anti-arthritic effects on type II collagen-induced arthritis in rats via suppression of inflammatory reactions, inhibition of invasion & migration and induction of apoptosis in synovial fibroblasts.
Biomed Pharmacother2019https://conductscience.org/library/papers/31545276PubMed
1932180036Antioxidants and antioxidant methods: an updated overview.Arch Toxicol2020https://conductscience.org/library/papers/32180036PubMed
2025230505Anti-inflammatory activity of constituents isolated from Terminalia chebula.Nat Prod Commun2014https://conductscience.org/library/papers/25230505PubMed

See all 42 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42945831Molecular mechanisms and therapeutic potential of Rasayana in cellular protection and healthy aging.J Ayurveda Integr Med2026https://conductscience.org/library/papers/42945831PubMed
39683707Comprehensive Review on Fruit of Terminalia chebula: Traditional Uses, Phytochemistry, Pharmacology, Toxicity, and Pharmacokinetics.Molecules2024https://conductscience.org/library/papers/39683707PubMed
38792262Study on Quality Characteristic of Chebulae Fructus and Its Adulterants and Degradation Pathway of Hydrolyzable Tannins.Molecules2024https://conductscience.org/library/papers/38792262PubMed
38473130Effects of Dietary Terminalia chebula Extract on Growth Performance, Immune Function, Antioxidant Capacity, and Intestinal Health of Broilers.Animals (Basel)2024https://conductscience.org/library/papers/38473130PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36969583

GET https://conductscience.org/api/papers/v1/36969583/references?page=2